Maria Isabel Roberti
Pediatric Nephrology Livingston, NJ Medical Doctor
NPI 1376580415 CMS profile 658744
94 Old Short Hills Rd, Suite 304 East Wing, Livingston, NJ 07039
General payments
$187
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$15,505
Through program year 2025, Maria Isabel Roberti of Livingston, NJ is reported in the CMS Open Payments database as having received $187 across 7 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $15,505 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 43rd percentile of Pediatric Nephrology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $57 | 3 | |
| 2023 | General | $15 | 1 | |
| 2021 | General | $115 | 3 |
Beside peers
- Maria Isabel Roberti
- Pediatric Nephrology median
- Middle half of Pediatric Nephrology
- National median
In program year 2025, general payments to Maria Isabel Roberti were reported at $57. Among 327 Pediatric Nephrology profiles paid that year, the median was $131 and the middle half received between $47 and $474.
Show as a table
| Year | Maria Isabel Roberti | Pediatric Nephrology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $123 | $48–$353 | $163 |
| 2020 | $0 | $146 | $24–$2,251 | $114 |
| 2021 | $115 | $138 | $26–$1,371 | $132 |
| 2022 | $0 | $93 | $25–$427 | $149 |
| 2023 | $15 | $105 | $30–$375 | $160 |
| 2024 | $0 | $123 | $40–$481 | $164 |
| 2025 | $57 | $131 | $47–$474 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
12
Drug cost
$209
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Nitrofurantoin Nitrofurantoin Macrocrystal | Brand | 12 | $209 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,003 Part D prescribers listed as Nephrology; they describe a distribution and say nothing about conduct.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Nephrology in New Jersey
Mahmoud Loghman-Adham
Pediatric Nephrology · Nutley, NJ
Kenneth Lieberman
Pediatric Nephrology · Hackensack, NJ
Vikas Dharnidharka
Pediatric Nephrology · New Brunswick, NJ
Shefali Vyas
Pediatric Nephrology · West Orange, NJ
Maria Sharma
Pediatric Nephrology · Passaic, NJ
Guillermo Hidalgo
Pediatric Nephrology · Neptune, NJ
Related records
Pediatric Nephrology in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Nephrology
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.